Member access

4-Traders Homepage  >  Shares  >  SHANGHAI STOCK EXCHANGE  >  Jiangzhong Pharmaceutical Co Ltd    600750   CNE000000M80

End-of-day quote. End-of-day quote SHANGHAI STOCK EXCHANGE - 12/17
21.38 CNY   -2.73%
 SummaryQuotesChart AnalysisAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
12/11/2014 12/12/2014 12/15/2014 12/16/2014 12/17/2014 Date
22.35(c) 21.98(c) 22.19(c) 21.98(c) 21.38(c) Last
5 983 141 5 091 356 5 013 207 3 980 045 5 712 059 Volume
-0.27% -1.66% +0.96% -0.95% -2.73% Change
More quotes
Company
Jiangzhong Pharmaceutical Co. Ltd. is engaged in the manufacture and sale of pharmaceutical products.Main products consist of Chinese, water-soluble and botanical medicines; penicillin injection and raw materials; capsules; antibiotics and others.Other activities include wholesale and retail of... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Surperformance© ratings of Jiangzhong Pharmaceutical
Trading Rating : Investor Rating :
More Ratings
Chart JIANGZHONG PHARMACEUTICAL
Duration : Period :
Jiangzhong Pharmaceutical  Technical Analysis Chart | 600750 | CNE000000M80 | 4-Traders
Full-screen chart
Financials ( CNY)
Sales 2014 3 174 M
EBIT 2014 246 M
Net income 2014 210 M
Finance 2014 374 M
Yield 2014 1,34%
Sales 2015 3 518 M
EBIT 2015 311 M
Net income 2015 267 M
Finance 2015 458 M
Yield 2015 1,47%
PER 2014 31,72
PER 2015 25,02
EV / Sales 2014 1,96x
EV / Sales 2015 1,75x
Capitalization 6 597 M
More Financials
Latest news on JIANGZHONG PHARMACEUTICAL

- No features available -

More news
Sector news
1d ago TAKEDA PHARMACEUTICAL : Announces Appointment of Andrew Plump, M.D., Ph.D., as C..
1d ago AMGEN : Announces 30 Percent Increase In 2015 First Quarter Dividend
1d ago ZOETIS : Declares First Quarter 2015 Dividend; Board Approves 15% Payment Increa..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF